|
Post by chong9 on Nov 9, 2017 0:24:40 GMT -5
They have patients without afrezza. Also there were few pre-qual conditions to get on afrezza group.
|
|
|
Post by mnholdem on Nov 9, 2017 5:50:06 GMT -5
Eligible participants (N=400) with an A1c 7.5-10.5% already prescribed a rapid-acting insulin will be randomized to one of two groups: (1) One Drop | Premium 'On Track' (i.e., use the One Drop | Mobile app with in-app diabetes education accredited by the American Diabetes Association with supplemental Afrezza content and a live Certified Diabetes Educator messaging in the app, the 'Chrome' Bluetooth-connected blood glucose meter that uploads blood glucose values in the app, and 150 test strips per month) in combination with Afrezza treatment (n=200) or (2) One Drop | Premium 'On Track' plus their current rapid-acting insulin (n=200).
200 participants in each group.
|
|
|
Post by sayhey24 on Nov 9, 2017 6:32:38 GMT -5
As I said a while ago I am a bit surprised this is being done against current RAA users and not metformin users. Few PWDs on insulin are going to change what their doctor told them to do with out direct one on one contact with someone who they trust.
IMO, it was poorly conceived.
|
|
|
Post by roseylv on Nov 9, 2017 10:40:05 GMT -5
Didn’t Mike C comment on the number of patients that one drop had signed up? He didn’t give a number but used a phrase.
Can Anyone help?
|
|
|
Post by sportsrancho on Nov 9, 2017 13:34:41 GMT -5
Didn’t Mike C comment on the number of patients that one drop had signed up? He didn’t give a number but used a phrase. Can Anyone help? The next trial here, the bottom four and the blue bars are initiated by investigators. So the next blue bar here is an Afrezza One Drop study that is focused on the Type II market. That trial has started screening and has had several patients go through the screening process and I believe one or two have enrolled. We don't have as much transparency in some of these just because they are independent. Another trial that is the first time we are announcing here that you may have seen in clinical trials that is called Levin study. This is an investigator in the Maryland area and he's initiating mealtime Afrezza in uncontrolled Type II patients and that will start enrolling next week. And the final trial that we are interested in watching is the Yale study that is the closed loop system looking at the artificial pancreas. We've heard from several investigators that the best way for artificial pancreas to function and have a tight range of control is by adding Afrezza which speaks to our speed of action. This trial we expect to start in the next few weeks.
|
|
|
Post by sportsrancho on Dec 7, 2017 12:29:15 GMT -5
Emails went out to all one drop users and members about Afrezza. “Have you heard about Afrezza?” Picture of the Dreamboat. “ Would you like to?” “Do you want to try Afrezza inhalable insulin? know anybody who might?”
Looking for type two diabetics ....
|
|
|
Post by hellodolly on Dec 7, 2017 12:37:17 GMT -5
Emails went out to all one drop users and members about Afrezza. “Have you heard about Afrezza?” Picture of the Dreamboat. “ Would you like to?” “Do you want to try Afrezza inhalable insulin? know anybody who might?” Looking for type two diabetics .... "Start spreading the news..."
|
|
|
Post by akemp3000 on Dec 7, 2017 12:44:53 GMT -5
Emails went out to all one drop users and members about Afrezza. “Have you heard about Afrezza?” Picture of the Dreamboat. “ Would you like to?” “Do you want to try Afrezza inhalable insulin? know anybody who might?” Looking for type two diabetics .... Going out to all one drop users is fantastic news and targets a great demographic: The One Drop | Mobile app is available for free on iOS and Android in seven different languages (Russian, French, German, Chinese, Spanish, Arabic, and English) and is used by people with diabetes in over 200 countries worldwide. Full integration with Apple HealthKit, Google Fit, Dexcom, and Fitbit allows One Drop | Mobile users to sync blood glucose, fitness, nutrition, and other health data from thousands of apps and devices. Users schedule medication reminders, view statistics, set goals, track A1c and weight, get data-driven insights, provide and receive support from other users, and get tips and advice to help with diabetes management.
|
|
|
Post by goyocafe on Dec 7, 2017 12:56:37 GMT -5
Emails went out to all one drop users and members about Afrezza. “Have you heard about Afrezza?” Picture of the Dreamboat. “ Would you like to?” “Do you want to try Afrezza inhalable insulin? know anybody who might?” Looking for type two diabetics .... Any idea when they did that?
|
|
|
Post by sportsrancho on Dec 7, 2017 12:58:46 GMT -5
Emails went out to all one drop users and members about Afrezza. “Have you heard about Afrezza?” Picture of the Dreamboat. “ Would you like to?” “Do you want to try Afrezza inhalable insulin? know anybody who might?” Looking for type two diabetics .... Any idea when they did that? Today.
|
|
|
Post by dg1111 on Dec 7, 2017 13:02:42 GMT -5
Do we have an idea of how many people this email would have gone out to?
|
|
|
Post by sellhighdrinklow on Dec 7, 2017 15:43:30 GMT -5
Do we have an idea of how many people this email would have gone out to? I received their email last week.
|
|
|
Post by promann on Dec 7, 2017 15:53:42 GMT -5
Do we have an idea of how many people this email would have gone out to? I think their are more then 100,000 people on one drop maybe someone has the correct number but this is great to hear that’s a lot of people getting notified of Afrezza if just 10% take notice and ask their doctor about it and 1/2 of them try it that’s 5,000 more new scripts
|
|
|
Post by sportsrancho on Dec 7, 2017 16:23:39 GMT -5
A-One Trial Request Dear Healthcare Provider,
I’m eligible for the A-One research trial. This trial enrolls people with type 2 diabetes prescribed a rapid-acting insulin are randomly assigned to one of two treatment groups. One group receives a One Drop | Premium subscription and maintains medication as usual. The second group receives a One Drop | Premium subscription and is asked to replace their current injectable, rapid-acting insulin with inhaled insulin: Afrezza.
One Drop | Premium is a diabetes management solution. It includes the:
– One Drop | Mobile app for tracking self-care and health data, getting tips, recipes, advice, reminders to take medications, and support from other One Drop users while learning from their data.
– One Drop | Experts program that provides 24/7 in-app diabetes support from a Certified Diabetes Educator (CDE) and the first digitally-delivered diabetes education program accredited by the American Diabetes Association.
– One Drop | Chrome Bluetooth-connected blood glucose meter that uploads readings into the app. Test strips, as many as I need, are delivered to my door.
I’ve been assigned to the Afrezza + One Drop | Premium group.
As a participant in this condition, I’m being asked to substitute my current rapid-acting insulin with a 3-month supply of Afrezza. That’s where you come in. Would you please provide me with this prescription?
The study team will supply me with a voucher for Afrezza at no cost, plus my own FEV1 meter to use regularly. My One Drop | Expert CDE/coach will educate me about how to use Afrezza and will offer tips and support, but will not be a substitute for clinical care. He/she will advise me to come to you with any clinical questions/concerns.
The study team requests the 3-month prescription be written for either:
1) Afrezza 180-Count Titration Pack 4/8 units, Dispense 1 box 180 ct NDC Number 47918-0880-18 (Inhale by mouth, three times daily, at the beginning of meals or as directed for 30 days). Up to 2 refills.
**OR**
2) Afrezza 180-Count Titration Pack 4/8/12 units, Dispense 1 box 180 ct NDC Number 47918-0902-18 (Inhale by mouth, three times daily, at the beginning of meals or as directed for 30 days). Up to 2 refills.
Questions?
Please contact the study team at AOne@onedrop.today or the Principal Investigator, Chandra Osborn, PhD, MPH, at chandra@onedrop.today or 860-424-2858 .
|
|
|
Post by casualinvestor on Dec 7, 2017 16:25:13 GMT -5
One Drop Mobile is the free app with ?no? official coaching. It has 867 reviews and has been downloaded 100k - 500k times from the app store. # of downloads is usually a lot higher than the number of current users.
I'd love to know how many subs One Drop has with Plus and Premium, as well as how many Chrome's have been sold.
|
|